Lyell Immunopharma, Inc.LYELNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank0
3Y CAGR-28.7%
5Y CAGR-17.8%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-28.7%/yr
Annual compound
5Y CAGR
-17.8%/yr
Recent deceleration
Percentile
P0
Near historical low
vs 5Y Ago
0.4x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $340.05M | -30.7% |
| 2024 | $490.86M | -34.6% |
| 2023 | $750.03M | -20.0% |
| 2022 | $937.56M | -16.8% |
| 2021 | $1.13B | +24.1% |
| 2020 | $908.28M | +63.5% |
| 2019 | $555.63M | - |